Idorsia AG

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

116.28%

Market Cap

1.75 Bil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.56 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE6.67 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 09:56:38 PM
DAILY VOLUME (UNITS)624
DAILY HIGH / LOW6.8356.67
PREV. DAY'S PRICE6.8 (07/21)
CHANGE DAY BEFORE
-0.13
-1.91 %
52 WEEK HIGH / LOW8.16 (06/30)2.538 (08/21)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-1.72-1.52-0.56-0.64-0.36
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
-----
PRICE - SALES RATIO
2.471.334.14--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A2DTEB
ISIN
CH0363463438
SYMBOL
19T
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
IDORSIA AG SF-,05
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Swiss Franc
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
263.06 Mil.
MARKET CAPITALISATION
1.75 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
2.64 %
11.75 %
70.68 %
76.81 %
116.28 %
--
44.87 %
HIGH6.898.168.168.168.16--8.16
LOW6.095.983.783.112.54--3.11

Dividende

pro Aktie
IDORSIA AG SF-,05 does not deliver dividend information

Company profile

Idorsia Ltd. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of medicines for medical needs. It operates through the following geographical segments: Switzerland, United States, Japan, and EUCAN. The company was founded on March 3, 2017 and is headquartered in Allschwil, Switzerland.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.